Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AnaptysBio Inc ANAB

Healthcare Biotechnology
AnaptysBio, Inc. is a clinical-stage biotechnology company focused on delivering immunology therapeutics. The Company is developing immune cell modulators, including two checkpoint agonists for autoimmune and inflammatory disease: rosnilimab, its PD-1 agonist, in a Phase 2b trial for the treatment of rheumatoid arthritis and in a Phase 2 trial for the treatment of ulcerative colitis; and ANB032... see more

Recent & Breaking News (NDAQ:ANAB)

CLASS ACTION UPDATE for LK, TLRY and ANAB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA April 3, 2020

AnaptysBio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In AnaptysBio, Inc. To Contact The Firm

Newsfile April 3, 2020

ANAB INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 3, 2020

CLASS ACTION UPDATE for WWE, CRON and ANAB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA April 3, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed, Important Deadlines Established

GlobeNewswire April 2, 2020

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 2, 2020

SHAREHOLDER ALERT: MGPI ANAB VMW: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

ACCESSWIRE IA April 2, 2020

ANAB SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire April 2, 2020

SHAREHOLDER ALERT: CLAIMSFILER REMINDS ANAB, SSL, XP INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

GlobeNewswire April 1, 2020

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Exela Technologies, RTI Surgical, DouYu, and AnaptysBio and Encourages Investors to Contact the Firm

GlobeNewswire April 1, 2020

ANAPTYSBIO, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for Southern District of California against AnaptysBio, Inc.

GlobeNewswire April 1, 2020

SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 1, 2020

CLASS ACTION UPDATE for TUP, BDX and ANAB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE IA April 1, 2020

ANAB INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies AnaptysBio, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA April 1, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed, Important Deadlines Established

ACCESSWIRE IA March 31, 2020

ANAB Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against AnaptysBio, Inc. (NASDAQ: ANAB); Lead Plaintiff Deadline is May 26, 2020

PR Newswire March 31, 2020

ANAPTYSBIO SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AnaptysBio, Inc. - ANAB

Business Wire March 31, 2020

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WWE, ANAB and HAFC

ACCESSWIRE IA March 31, 2020

ONE STOCK SYMBOL INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AnaptysBio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA March 31, 2020

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of INO, ANAB and HAFC

ACCESSWIRE IA March 31, 2020